DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q1 2016. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $162,000 | -18.6% | 40,443 | -0.2% | 0.00% | -100.0% |
Q3 2019 | $199,000 | -19.8% | 40,543 | -0.5% | 0.00% | 0.0% |
Q2 2019 | $248,000 | +3.3% | 40,743 | -1.5% | 0.00% | 0.0% |
Q1 2019 | $240,000 | -56.2% | 41,354 | +1.7% | 0.00% | -50.0% |
Q4 2018 | $548,000 | -29.9% | 40,678 | +1.0% | 0.00% | 0.0% |
Q3 2018 | $782,000 | -21.1% | 40,277 | +3.9% | 0.00% | 0.0% |
Q2 2018 | $991,000 | +27.5% | 38,765 | +0.5% | 0.00% | 0.0% |
Q1 2018 | $777,000 | +0.4% | 38,562 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $774,000 | -1.9% | 38,562 | +1.2% | 0.00% | 0.0% |
Q3 2017 | $789,000 | +43.7% | 38,102 | +2.7% | 0.00% | +100.0% |
Q2 2017 | $549,000 | -7.3% | 37,102 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $592,000 | +26.8% | 37,102 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $467,000 | -54.6% | 37,102 | +1.1% | 0.00% | -66.7% |
Q3 2016 | $1,028,000 | -14.1% | 36,702 | +7.3% | 0.00% | 0.0% |
Q2 2016 | $1,197,000 | +201.5% | 34,202 | +135.8% | 0.00% | +200.0% |
Q1 2016 | $397,000 | – | 14,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |